Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.
Press releases published on April 1, 2025
ASP Isotopes Inc. Completes Commissioning of First Quantum Enrichment Laser System and Starts Production of Commercial Samples of Ytterbium-176
GlobeNewswire
·
April 1, 2025
- Ytterbium-176 is a critical material used in the production of radioisotopes for oncology treatments, including Novartis’ Pluvicto. - The Company expects to be able to achieve a 99.75% enrichment for Ytterbium-176 and offer highly enriched Ytterbium-176 …
Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson’s Disease at AD/PD 2025
GlobeNewswire
·
April 1, 2025
Solengepras showed evidence of potential benefit in functional and non-motor symptoms versus placebo as measured by MDS-UPRDS Parts I, II, NMSS, and ESS, consistent with its novel non-dopaminergic mechanism of action This investigational treatment was …
Unity Consortium Kicks Off Adolescent Immunization Action Week (AIAW25) to Help Parents and Adolescents Stay on TASK with Recommended Immunizations
GlobeNewswire
·
April 1, 2025
AIAW 2025 Runs April 7-11 to Encourage Well-Visits and Recommended Immunizations VENTNOR CITY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- UNITY® Consortium, a non-profit dedicated to adolescent and young adult immunization and preventive health, urges …
Clearmind Launches its EDC System to Support its Phase I/II Clinical Trial of its MEAI-Based Treatment
GlobeNewswire
·
April 1, 2025
The clinical trial is designed to evaluate the safety, tolerability and efficacy of Clearmind’s innovative, psychedelic-derived, MEAI-based compound in individuals with alcohol addiction Vancouver, Canada, April 01, 2025 (GLOBE NEWSWIRE) -- Clearmind …
Guardforce AI Launches DVGO, an AI Travel Planning Tool Powered by Specialized AI Agents, in the United States
GlobeNewswire
·
April 1, 2025
NEW YORK, NY , April 01, 2025 (GLOBE NEWSWIRE) -- Guardforce AI Co., Limited (“Guardforce AI” or the “Company”) (NASDAQ: GFAI, GFAIW), a global integrated security provider specializing in secured logistics, Artificial Intelligence (AI), and Robot-as-a- …
Mayo Clinic Proceedings Publishes New Global Insulin Injection Recommendations
GlobeNewswire
·
April 1, 2025
PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark publication in the Mayo Clinic Proceedings. The …
Mitolyn Reviews DON’T SKIP UNTIL SEE THIS, Authentic Case Study, it a Scam or Does It Actually Aid in Weight Loss?
GlobeNewswire
·
April 1, 2025
JUPITER, Fla., April 01, 2025 (GLOBE NEWSWIRE) -- Mitolyn optimizes mitochondrial activity to improve metabolism, fat burning, and long-lasting energy. It bills itself as a mitochondrial support supplement that maximizes the body's natural fat-burning and …
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
April 1, 2025
Lab network revenue increased by 33% year over year, reflecting strong demand for ColoAlert® in EuropeOperating loss decreased by 30% and net loss by 18%, driven by targeted cost reductions and a sharper strategic focusBERKELEY, Calif. and MAINZ, Germany, …
Nkarta to Participate in an April Investor Conference
GlobeNewswire
·
April 1, 2025
SOUTH SAN FRANCISCO, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, today announced its participation in the following investor conference: 24th …
Mersana Therapeutics Announces Upcoming Oral Presentation of Emi-Le Clinical Data at European Society for Medical Oncology (ESMO) Breast Cancer 2025 Annual Congress
GlobeNewswire
·
April 1, 2025
CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of …
Candel Therapeutics Announces Publication of Phase 1b Clinical Trial Data on the Combination of CAN-2409 and Nivolumab plus Standard of Care in Newly Diagnosed High-Grade Glioma Patients
GlobeNewswire
·
April 1, 2025
NEEDHAM, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …
Phathom Pharmaceuticals Announces Leadership Succession
GlobeNewswire
·
April 1, 2025
FLORHAM PARK, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced that Steven …
Coherus Announces Repurchase of Approximately $170 Million of Convertible Notes
GlobeNewswire
·
April 1, 2025
– Remaining $60 Million of outstanding convertible notes to be repurchased post-close of pending UDENYCA divestiture – REDWOOD CITY, Calif., April 01, 2025 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus” or the “Company,” NASDAQ: CHRS) announced …
electroCore to Participate at the Needham Virtual Healthcare Conference
GlobeNewswire
·
April 1, 2025
ROCKAWAY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the Needham Virtual Healthcare Conference taking place …
Marker Therapeutics to Present at Canaccord Genuity’s Horizons in Oncology Conference
GlobeNewswire
·
April 1, 2025
HOUSTON, April 01, 2025 (GLOBE NEWSWIRE) -- MARKER THERAPEUTICS, INC. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid …
XIMEA Reveals Medium Format Camera with 4.1" IMX811 Sensor: Highest Resolution - 245 Mpix
GlobeNewswire
·
April 1, 2025
MUENSTER, Germany, April 01, 2025 (GLOBE NEWSWIRE) -- XIMEA, the innovator of high-resolution cameras with a unique feature set, expands the xiX-XL family by introducing the currently highest resolution cameras using a backside illuminated Sony IMX811 …
BitMEX Unveils Enhanced BMEX Token Utility with Increased Staking Rewards and Lower Trading Fees
GlobeNewswire
·
April 1, 2025
MAHE, Seychelles, April 01, 2025 (GLOBE NEWSWIRE) -- BitMEX, the OG crypto derivatives exchange, today announced significant enhancements to its BMEX Token ecosystem, introducing higher staking rewards, reduced trading fees, and expanded token utility. …
Avadel Pharmaceuticals to Present at the 24th Annual Needham Healthcare Conference
GlobeNewswire
·
April 1, 2025
DUBLIN, April 01, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that members of management will participate in a fireside chat at the …
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 1, 2025
MORRISVILLE, N.C., April 01, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease, today announced that the company will provide an overview …
Merus to Participate in a Fireside Chat at the 24th Annual Needham Virtual Healthcare Conference
GlobeNewswire
·
April 1, 2025
UTRECHT, The Netherlands and CAMBRIDGE, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS), an oncology company developing innovative, full-length multispecific antibodies and antibody drug conjugates (Biclonics®, Triclonics® and ADClonics …